Number of Credits: 1 CME Credit
Credit Type:
After completing this course, the participant should be able:
Lyndon M. Hill, MD
Professor Obstetrics and Gynecology
Medical Director Ultrasound
Magee Women's Hospital
Pittsburgh, PA
The Institute for Advanced Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
These credits are accepted by the American Registry for Diagnostic Medical Sonography (ARDMS).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
Physicians, sonographers and others who perform and/or interpret obstetrical ultrasound.
In order to complete this program you must have a computer with a recent browser version. You must also have the capability to display and print PDF files in order to view and print out your certificate. (Note: Your CME certificate is stored in your account and is available at any time.)
For any questions or problems concerning this program or for problems related to the printing of the certificate, please contact IAME at 802-824-4433 or info@iame.com.
This activity is designed to be completed within the time designated. To successfully earn credit, participants must complete the activity during the valid credit period. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME credit:
Your CME credits will be archived in the account you create and can be accessed at any time.
Estimated Time for Completion: approximately 1 hour
Date of Release: December 15, 2009
Date of Last Review: May 20, 2018
Expiration Date: May 20, 2021
In compliance with the Essentials and Standards of the ACCME, the author of this CME tutorial is required to disclose any significant financial or other relationships they may have with commercial interests.
Dr. Lyndon Hill discloses no financial relationships with commercial interests.
No one at IAME who had control over the planning or content of this activity has relationships with commercial interests.
Implantation
An adequate endometrial thickness (? 8 mm)1, as well as appropriate vascularization are required for implantation. The uterine glands provide early embryonic nutrition through the placenta intervillous space (Fig. 1)2.
![]() |
Figure 1 - Posterior implantation of a 4 week gestational sac (arrow). Fluid is present within the endometrial cavity (curved arrow). To view an enlargement, click on the image. |
Implantation most commonly occurs on the posterior uterine wall approximately 0.5 cm to 1.5 cm from the fundus (Fig. 2)3. Kawakami et al4 reported that 17 of 21 gestational sacs were located on the ipsilateral uterine wall to the ovulating ovary. There is a decrease in uterine artery impedance prior to implantation. A delay in this process5 and/or poor endometrial blood flow may result in miscarriage2.
![]() |
Figure 2 - 3D coronal image of the endometrial cavity. A gestational sac (4.6 menstrual weeks) is appropriately implanted in the posterior endometrium. To view an enlargement, click on the image. |
Gestational Sac
The 1st trimester gestational sac is structurally and functionally distinct. The embryo develops in an environment that is lower in oxygen then that of the fetus.
Part of the cytotrophoblast differentiates into extravillous trophoblast that invades the spiral arteries and adapts these vessels to provide the increased blood flow required in the 2nd and 3rd trimesters. However, as they invade the vessels in the early 1st trimester, they form plugs to occlude the spiral arteries and prevent maternal blood from entering the intervillous space6.
Antioxidant enzymes are not expressed by the syncytiotrophoblast until 8 to 9 weeks’ menstrual age. Hence, the early trophoblast is extremely sensitive to oxygen mediated damage. As these enzymes develop, the trophoblast plugs loosen and the placenta is exposed to increasing oxygen concentrations6.
In two-thirds of early pregnancy failures, there is defective placentation with reduced cytotrophoblast invasion and impaired formation of the trophoblastic plugs. The premature onset of the maternal circulation to the villi increases oxygen concentration and thereby impairs syncytiotrophoblast function. This results in a fall in hCG and subsequent miscarriage7.
Significant intervillous flow is not well established until 10 weeks’ menstrual age8. The intraplacental oxygen concentration increases from < 20 mm of mercury at 10 weeks’ menstrual age to > 50 mm of mercury at 12 weeks’ due to the onset of the intervillous circulation9. Early Doppler studies10 could not detect intervillous blood flow until after 12 weeks’ menstrual age. Burton et al8, therefore, suggested that one of the functions of trophoblastic plugging of the spiral arteries was to restrict maternal blood flow into the intervillous space. With more sensitive Doppler equipment intervillous flow has been detected throughout the 1st trimester with a significant increase after 11 weeks’ menstrual age11. The dissipation of the intervillous plugs begins at the periphery of the placenta at 8 weeks’ menstrual age12. Hence, the development of the intervillous circulation seems to increase progressively throughout the 1st trimester13. In patients with a threatened miscarriage, a subchorionic hemorrhage results from bleeding in this peripheral area. However, with an embryonic demise, bleeding may occur centrally or throughout the placenta7.
The early gestational sac refers to the chorionic cavity. The gestational sac may be visualized with transvaginal sonography as early as 4 to 4.5 weeks’ menstrual age14. A gestational of 5 mm is consistent with 5 weeks’ menstrual age. The echogenic rim around the gestational sac (? 2 mm) is due to the surrounding chorionic villi and decidual reaction15.
The fluid in the amniotic cavity is anechoic. The proteinaceous material in the chorionic cavity produces low-level echoes (Fig. 3)16. Protein electrophoresis indicates that the chorionic fluid is an ultra-filtrate of maternal serum. The presence of a higher concentration of hCG in the chorionic cavity than in maternal serum indicates that there is a direct pathway between the trophoblast and chorionic cavity. Hence, the chorionic cavity provides a nutritional pathway to the embryo prior to the development of the uteroplacental circulation7. Maternal hyperglycemia impairs the function and structure of the yolk sac and is believed to be associated with diabetes related malformations17. Human chorionic gonadotropin [hCG] levels indicate the health of trophoblastic tissue. In some cases of anembryonic pregnancies the Beta hCG level may be normal for the patient’s true gestational age and sonographically the trophoblastic reaction (echogenic rim) has a normal appearance and thickness. Low levels of Beta hCG are associated with a poor decidual reaction and a thin echogenic lining of < 2 mm15,18.
![]() |
Figure 3 - 8.4 week gestational sac. The proteinaceous material in the chorionic cavity (arrow) is apparent. To view an enlargement, click on the image. |
Discriminatory Zone
HCG that is produced by trophoblastic tissue is detectable 8 days after conception19. The concept of a discriminatory bhCG zone at which a gestational sac should be visualized with ultrasound was introduced by Kadar et al20. A range of 1,000-2,000 mIu/ml is widely accepted for transvaginal sonography21. However, biologic variability in singleton gestations and the possibility of twins must be considered. Nearly all intrauterine gestational sacs should be identified by an bhCG of 3,000 mIu/ml22. A yolk sac is identified by a bhCG of 5,000 mIu/ml and embryonic cardiac activity is visualized by a bhCG of 15,000 mIu/ml14.
Chorionic Cavity
The chorionic fluid volume approximately doubles between 6 and 8 weeks’ menstrual age. The maximum chorionic cavity fluid volume of 6 ml occurs at approximately 9 weeks’ menstrual age23. By 10 weeks’ gestation embryonic renal function is initiated, resulting in a rapid expansion of the amniotic cavity. By the end of the 2nd trimester the amnion and chorion have fused.
The mean gestational sac diameter is determined by averaging three perpendicular diameters (Fig. 4). Between 5 and 6 menstrual weeks, the gestational sac normally increases in size by 1 mm/day in mean diameter7. Prior to visualization of the embryo, menstrual age (days) can be calculated by adding 30 to the mean sac diameter19. The mean gestational sac diameter has a reported variability that ranges from ± 7 to ± 12 days24. Hence, once a crown-rump length is visualized, its increased accuracy indicates that it should be used for gestational age assessment.
![]() |
Figure 4 - Three-dimensional volume of gestational sac. To view an enlargement, click on the image. |
Prior to 9 weeks’ menstrual age, a small gestational sac (Fig. 5), i.e. small chorionic cavity, is one factor that has been associated with a higher miscarriage rate. Bromley et al25 followed 16 pregnant women with a mean sac diameter minus crown-rump length < 5 mm and reported a miscarriage rate of 94% (15 of 16 cases). In one retrospective study, a small gestational sac was present before embryonic demise in 10.7% of cases26. The predictive value of small gestational sac is also dependent upon the clinical history (i.e. maternal age, presence or absence of vaginal bleeding, etc).
![]() |
Figure 5 - Small gestational sac: 5.4 week gestational sac; 7.0 week crown-rump length. To view an enlargement, click on the image. |
Although the gestational sac dimensions correlate with gestational age, a cut-off to accurately differentiate between normal pregnancies and miscarriages has not been established. Rempen et al27 suggested an empty gestational sac cut-off of > 18 mm was diagnostic of a non-viable pregnancy. However, Elson et al28 were able to document two viable pregnancies with an empty sac > 18 mm. Luise et al29 subsequently defined an anembryonic pregnancy as a gestational sac > 20 mm without a yolk sac. Hence, whenever there is uncertainty about a patient’s gestational age parameters and/or viability on an ultrasound exam, a repeat scan at an interval of one week should be obtained before a definitive diagnosis is made.
Traditionally, embryonic resorption (i.e. prior sonographic documentation of an embryo with cardiac activity that is no longer detectable) has not been considered the same as an anembryonic pregnancy. However, anembryonic pregnancies have been found to contain alpha-fetoprotein of yolk sac origin. The latter finding indicates that an embryo developed until at least 14 days after ovulation when a secondary yolk sac would be present. Most anembryonic pregnancies are, therefore, pregnancies in which the embryo has been absorbed rather than never present30.
Amniotic Cavity
Between 6.5 and approximately 10 weeks’ menstrual age the diameter of the amniotic cavity is approximately 10% greater than the crown-rump length (Fig. 6)27. Hence, there is a linear correlation between amniotic cavity volume and gestational age. Once the amniotic cavity is easily detectable with transvaginal sonography, an embryo should also be identified. A disproportionately enlarged amniotic cavity in the first half of the 1st trimester is associated with an early embryonic demise (Fig. 7)31. An empty amnion is also associated with early pregnancy failure32.
![]() |
||||
Figure 6 - Amniotic cavity (arrows) at 7 weeks’ menstrual age. | Figure 7 - Embryonic demise with an enlarged amniotic cavity (arrow). | |||
To view an enlargement, click on the image. |
Yolk Sac
The yolk sac (Fig. 8) plays a critical role in embryogenesis. The functions of the yolk sac include:
![]() |
Figure 8 - Normal yolk sac (arrow) at 7.5 weeks’ menstrual age. To view an enlargement, click on the image. |
The maximum diameter of the yolk sac is approximately 6 mm at 10 weeks’ menstrual age33.
Yolk sac vascularity is characterized by a low velocity and absence of diastolic flow. The gradual decline in yolk sac function after 9 weeks’ menstrual age coincides with a progressive decrease in yolk sac vascularity just as the placenta takes over the metabolic demands of a rapidly growing embryo34.
There are reports of yolk sac diameters > 7 mm being associated with embryonic demise (Fig. 9)35. Other studies have not found a significant correlation between yolk sac diameter and embryonic outcome36.
The yolk sac is normally circular. An abnormal yolk sac shape has a poor sensitivity (29%) and a 47% positive predictive value for predicting miscarriage37. An abnormality in yolk sac size or shape is due to poor embryonic development or demise rather than being the primary cause of a 1st trimester loss. An impairment in calcium transport leads to an accumulation of calcium in the yolk sac. A calcified yolk sac without blood flow is, therefore, indicative of a long standing embryonic demise (Fig. 10)34.
![]() |
||||
Figure 9 - Embryonic demise with an enlarged yolk sac (arrow). | Figure 10 - Calcified yolk sac (ys) with an embryonic demise of 2 weeks. | |||
To view an enlargement, click on the image. |
Crown-Rump Length
Variations in ovulation, fertilization or implantation may explain some of the differences found in crown-rump lengths of specific gestational ages. As a result, crown-rump length dating tables using optimal menstrual history tend to underestimate gestational age by 2 to 3 days when compared to tables constructed from patients with a known conception date38. Once growth begins, normal embryos have similar growth curves39.
The embryo is present from 9 days after conception. The embryonic period begins at 3 weeks after conception (5 weeks’ menstrual age) and continues until organogenesis is complete (8 weeks after conception; 10 weeks’ menstrual age)19. The fetal period begins after 10 weeks’ menstrual age and is a period of differentiation and growth, not development.
Until the embryo is 4 mm, it is straight and the measurement obtained is actually the longest visible length. After a crown-rump length of 4 mm, there is rapid head growth and the body begins to curve. Hence, a crown-rump length measurement is actually a “neck-rump” length (Fig. 11). By 7 weeks and 3 days menstrual age the embryonic head and body can be distinguished40. By 18 mm (8 weeks’ menstrual age) a true crown-rump length measurement can be obtained (Fig. 12)41.
![]() |
||||
Figure 11 - “Neck-rump” length of 0.59 cm at 6.2 weeks’ menstrual age. | Figure 12 - Crown-rump measurement at 8.9 weeks’ menstrual age. | |||
To view an enlargement, click on the image. |
The crown-rump length in the early part of the 1st trimester increases by at least 0.9 mm per day. Hence, with normal growth, a change in embryo size can be observed in 2 days. The crown-rump length is reported to have a variability of ± 5-7 days in 95% of cases. Others have reported a 95% reference interval of ± 8.6 days24. Hadlock et al42 estimated the 95% confidence interval of a crown-rump length to be ± 8%.
Cardiac Activity
Embryonic cardiac activity can be documented by transvaginal sonography at a menstrual age of 5 weeks and 1 day. Hence, cardiac activity should be present when the embryo is > 2 mm. However, in 5-10% of normal embryos cardiac activity is not visualized between 2 and 4 mm43,44.Embryonic cardiac activity should be identified with a crown–rump length > 7 mm 44b. In order to minimize error, the diagnosis of an embryonic demise should not be made on a single visit, only on a follow-up examination 44c.
Embryonic cardiac activity is initially quite slow (82 to 101 beats per minute at 5 weeks’ menstrual age)(Fig. 13)45,46. The rate increases as the atrium initiates its pacemaker function. The heart rate increases by approximately 4 beats per minute per day46. The increase in heart rate is required to increase cardiac output for a growing embryo47.
![]() |
Figure 13 - Normal embryonic heart rate (94 bpm) at 5.6 weeks’ menstrual age. To view an enlargement, click on the image. |
Both maternal history and sonographic findings affect the fetal loss rate after detecting cardiac activity at 6-10 weeks’ menstrual age. For example, the incidence of embryonic loss after visualizing cardiac activity at 6-10 weeks increases from 4% at 20 years of age to 20% for women > 35 years old. As one would expect the miscarriage rate decreases with advancing gestation from 10% at 6 weeks to 3% at 10 weeks. First trimester vaginal bleeding increases the miscarriage rate by 2.6-fold48.
The three sonographic parameters that have been shown to have an association with embryonic success or failure include; appropriate gestational sac size, an appropriate crown-rump length for gestational age, and embryonic heart rate. Embryonic bradycardia is a poor prognostic sign49. A single observation of an embryonic heart rate < 80 beats per minute at 7 weeks’ menstrual age has a 70% sensitivity and 94% positive predictive value for an embryonic demise. The false positive rate of an embryonic bradycardia was documented by Merchiers et al45 who reported a case of transient bradycardia of 48 beats per minute that resulted in a normal pregnancy outcome. The embryonic demise rate between 6 and 7.1 weeks’ menstrual age increased as the initial heart rate falls50 and decreases as the heart rate rises. Doubilet and Benson51 reported a 60.6% 1st trimester demise rate with an embryonic bradycardia between 6-7 weeks’ menstrual age. If on a subsequent exam at 8 weeks’ gestation, the heart rate was normal, the demise rate was reduced by 25.4%. Even the latter result was significantly increased over the 7.2% demise rate in a control group with a normal embryonic heart rate. If a pregnancy with an embryonic bradycardia survives the 1st trimester, the loss rate during the remaining months of pregnancy is quite low52. However, the prevalence of structural and chromosomal anomalies is increased from 2.4% in controls to 5.4% in a group with an initial embryonic bradycardia who survive53. In contrast to an embryonic bradycardia, an embryonic tachycardia (? 135 bpm before 6.3 weeks’ menstrual age and ? 155 bpm between 6.3-7 weeks’ menstrual age) is not associated with an increase in miscarriage rate54.
The favorable outcome associated with the detection of a normal embryonic heart rate (Table I) cannot be used with a history of recurrent miscarriage. In this high-risk group miscarriage or fetal death rates after documenting cardiac activity is approximately 17%55. Both gestational sac and embryonic growth are initially normal, but become abnormal prior to demise56. When both the mean gestational sac diameter and the crown-rump length are smaller then expected, Nazari et al57 found a 71% miscarriage rate with 3.5% false positive rate.
Table I. Miscarraige rate based on sonographic landmark obtained.
Sonographic Landmark |
Miscarriage Rate (%) |
Gestational sac |
11.5 |
Yolk sac |
8.5 |
5 mm embryo |
7.2 |
6-10 mm embryo |
3.3 |
> 10 mm embryo |
0.5 |
Derived from Goldstein SR. Obstet Gynecol 1992;80:670.
In some cases an embryonic bradycardia may be due to an underlying chromosomal abnormality58. However, the prevalence of karyotypic abnormalities with an embryonic bradycardia is the same as for spontaneous 1st trimester miscarriages in general59.
Developmental Landmarks
The sonographic appearance of developmental landmarks in early pregnancy occurs within well-defined gestational age time periods. A gestational sac and embryonic cardiac activity should be visualized in 95% of cases by 5.6 weeks and 6.6 weeks’ menstrual age, respectively60. The association between sonographic landmarks and subsequent miscarriage are outlined on Table I. Table II provides the menstrual age at which specific embryonic landmarks are detectable sonographically during organogenesis (weeks 5 to 10 menstrual age). The single cavity within the head visualized at 7 weeks’ menstrual age is the rhombencephalon (Fig. 14)40.
Table II.
Menstrual Age (weeks) |
Sonographic Landmark |
4
|
Gestational sac without yolk sac |
5
|
Yolk sac present |
6 |
Embryonic cardiac activity
|
7
|
Single ventricle without a falx
|
9
|
Falx visualized; mid-gut herniation; limb movements
|
Derived from:
Warren WB et al. Am J Obstet Gynecol 1989;161:747.
Timor-Tritsch IE et al. Am J Obstet Gynecol 1988;159:676-681.
![]() |
Figure 14 - The single cavity (arrow) present in the fetal head is the rhombencephalon. To view an enlargement, click on the image. |
Threatened Miscarriage
Vaginal bleeding prior to 6 weeks’ menstrual age has not been associated with an increased risk of miscarriage61. However, 1st trimester vaginal bleeding between 7 and 12 weeks’ menstrual age is associated not only with a 5-10% miscarriage rate, but also a higher risk of premature rupture of the membranes and pre-term labor62. The risk of miscarriage is directly related to the severity of vaginal bleeding. In the FASTER trial evaluation of 1st trimester bleeding, the odds ratio for subsequent miscarriage was 2.5 for patients with light vaginal bleeding, in contrast to an odds ratio of 4.2 in patients with heavy vaginal bleeding62.
In patients with 1st trimester vaginal bleeding, a retroplacental hematoma, in contrast to a marginal subchorionic hemorrhage is more predictive of subsequent miscarriage13.
There is not a direct relationship between the size of a subchorionic hematoma and outcome63.
A “chorionic bump” (Fig. 15) is a small hematoma that protrudes into the gestational sac. This sonographic finding in one study was associated with a live birth rate of < 50%64.
![]() |
Figure 15 - Chorionic bump (arrow) protruding into a gestational sac. To view an enlargement, click on the image. |
Seventy percent of 1st trimester miscarriages are chromosomally abnormal, of which 60% are autosomal trisomies59.
An incomplete miscarriage results in a heterogeneously thickened endometrial lining.
In one study expectant management for an incomplete miscarriage was significantly better than for a missed miscarriage65. Medical management with misoprostol may be as effective as surgical management for an incomplete miscarriage.
Hydatidiform Mole
A complete hydatidiform mole has a 46 xx chromosomal pattern with all of the chromosomes of paternal origin. One percent of complete moles are associated with a viable fetus because of a twin dizygotic gestation (i.e. a complete mole and a normal pregnancy)16.
The classic complete hydatidiform mole has a “swiss cheese” sonographic appearance representing the hydropic villi66. The size of the villi is correlated with gestational age64. Hence, in the 1st trimester only 50% of complete hydatidiform moles have a classic appearance (Fig. 16). The remaining cases may present as an anembryonic gestational sac or thick endometrium without the classic vesicles66,67. Excessive hCG production results in 2nd or 3rd trimester theca lutein cysts. In the 1st trimester the hCG level is low to normal for gestational age in two-thirds of cases62. Hence, theca lutein cysts are uncommon68.
![]() |
Figure 16 - 1st trimester hydatidiform mole. To view an enlargement, click on the image. |
A partial more is due to triploid (69, xxy) or rarely tetraploidy (92, xxxy). A gestational sac with an embryonic pole is present. The placenta is enlarged and contains hydropic villi68.
Hydropic changes in an early embryonic demise may look sonographically identical to a hydatidiform mole69.
Conclusion
Familiarity with normal embryological development, sonographic landmarks, and appropriate hCG levels provides the observer with the necessary tools to assess, not only normal development, but also pathologic conditions that occur in the 1st trimester.
References
IAME's Unlimited CME Plan is now the internet's best value for online CME in ultrasound.
Your CME credits are available at any time in your Online CME Control Panel. They are automatically transferred to the ARDMS/APCA CME Bank and RSNA's CME Gateway (when you provide your credentials).
"Information is very informative and valuable to my area of practice."
Angela Dorosky-Lisauskas RDMS, Canton, Ohio
© 1996 - 2019 IAME, All Rights Reserved | Privacy Policy
Cancellation & Refund Policy
Phone: 802.824.4433 | Fax: 802.824.3737